Meijuan Li

Meijuan Li

Company: Eisai

Job title: Vice President, Head of Biostatistics, Oncology Group

Seminars:

Driver Mutation Variant Allele Frequency (VAF) in Circulating Tumor DNA and Association with Clinical Outcome in NSCLC Patients with EGFR- and KRAS-Mutated Tumors 10:40 am

• Is ctDNA a good potential surrogate endpoint for survival time? • How can we implement ctDNA testing in trials in terms of surrogate endpoint monitoring?Read more

day: day 2 red

Utilizing ctDNA Dynamics to Guide Early Drug Development 12:05 pm

• Considerations and limitations when using ctDNA to detect genomic alterations in DDR genes • Early ctDNA dynamics to assess drug activity in early phase clinical trials • How early clinical trial results showing an interesting biological link between ctDNA levels & drug activity create questions for understanding tumor pathophysiologyRead more

day: day 2 red

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.